Back
Osisko Gold Royalties Vs. Surgery Partners Industry Stock Comparison
Buy
55
OR
Osisko Gold Royalties
Last Price:
17.96
Seasonality Move:
-5.17%
Buy
61
SGRY
Surgery Partners
Last Price:
31.39
Seasonality Move:
9.64%
Buy
55
Osisko Gold Royalties (OR)
is a Buy
Is Osisko Gold Royalties a Buy, Sell or Hold?
- The current Osisko Gold Royalties [OR] share price is $18.03. The Score for OR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- OR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Surgery Partners (SGRY)
is a Buy
Is Surgery Partners a Buy, Sell or Hold?
- The current Surgery Partners [SGRY] share price is $31.86. The Score for SGRY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- SGRY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
OR Stock Price Chart
What is Osisko Gold Royalties's stock price today?
-
The Osisko Gold Royalties share price today is $18.03
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OR is experiencing slight buying pressure.
SGRY Stock Price Chart
What is Surgery Partners's stock price today?
-
The Surgery Partners share price today is $31.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SGRY is experiencing slight buying pressure.
OR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 60.5 | Buy |
Chaikin Money Flow: | 164917 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.84 - 17.72) | Buy |
Bollinger Bands (100): | (15.93 - 17.43) | Buy |
SGRY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.4 | Buy |
Relative Strength Index (14 RSI): | 58.16 | Buy |
Chaikin Money Flow: | 299128 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.96 - 31.92) | Buy |
Bollinger Bands (100): | (24.68 - 30.12) | Buy |
OR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.28 | Buy |
20-day SMA: | 17.33 | Buy |
50-day SMA: | 17.19 | Buy |
200-day SMA: | 15.8 | Buy |
8-day EMA: | 17.51 | Buy |
20-day EMA: | 17.3 | Buy |
50-day EMA: | 17.08 | Buy |
200-day EMA: | 15.96 | Buy |
SGRY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.55 | Buy |
20-day SMA: | 30.69 | Buy |
50-day SMA: | 29.46 | Buy |
200-day SMA: | 29.08 | Buy |
8-day EMA: | 30.84 | Buy |
20-day EMA: | 30.58 | Buy |
50-day EMA: | 29.49 | Buy |
200-day EMA: | 29.1 | Buy |
Osisko Gold Royalties Earnings Growth & OR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.03 per share, an increase this year of $0.05 per share, and an increase next year of $0.09 per share.
Surgery Partners Earnings Growth & SGRY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.06 per share, an increase this year of $0.13 per share, and an increase next year of $0.25 per share.
Osisko Gold Royalties Technical Analysis
Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Surgery Partners Technical Analysis
Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |